Literature DB >> 2185314

Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.

P D Smith1, C L Lamerson, H L Wong, L M Wahl, S M Wahl.   

Abstract

We investigated the effect of recombinant human granulocyte-macrophage CSF (rhGM-CSF) on the accessory cell function of purified human monocytes. Compared with untreated monocytes, rhGM-CSF-treated monocytes promoted enhanced mitogen- and Ag-stimulated lymphocyte proliferation. This enhancement was significantly inhibited by mAb to rhGM-CSF. In experiments designed to define the mechanism of rhGM-CSF augmentation of accessory cell function, rhGM-CSF was shown to cause a dose-dependent increase in monocyte expression of surface HLA-DR molecules and stimulated secretion of IL-1, both important in monocyte T cell interactions. Further studies demonstrated that levels of HLA-DR and IL-1 mRNA were increased by rhGM-CSF, indicating transcriptional regulation of gene expression for HLA-DR and IL-1. Thus, rhGM-CSF augments accessory cell function by human monocytes, and this augmentation correlates with rhGM-CSF-induced increases in transcription of the HLA-DR and IL-1 genes leading to increased expression of surface HLA-DR and secretion of IL-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185314

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Cellular responses to human chondrocytes: absence of allogeneic responses in the presence of HLA-DR and ICAM-1.

Authors:  P Jobanputra; V Corrigall; G Kingsley; G Panayi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori.

Authors:  M Yoshida; Y Wakatsuki; Y Kobayashi; T Itoh; K Murakami; A Mizoguchi; T Usui; T Chiba; T Kita
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells.

Authors:  K Takahashi; K Asagoe; J Zaishun; H Yanai; T Yoshino; K Hayashi; T Akagi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.

Authors:  M R Young; M A Wright; M E Young
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Authors:  A A Hurwitz; T F Yu; D R Leach; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

Authors:  L W Kwak; H A Young; R W Pennington; S D Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?

Authors:  G J Locker; I Simonitsch; R M Mader; E Warlamides; M F Gnant; R Jakesz; H Rainer; G G Steger
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

9.  Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.

Authors:  V A Danis; G M Franic; D A Rathjen; P M Brooks
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

10.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.

Authors:  G van den Bosch; F Preijers; A Vreugdenhil; J Hendriks; F Maas; T De Witte
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.